Eden Bioscience Corporation Company Profile | EDEN Company Information

http://www.zirilla.it/user_detail.php?u=meraTramnen
We have incurred significant operating lossees since our inceptionin 1994. At Marcu 31, 2009, we had an accumulated deficitof $128.11 million. We incurred net losses of $0.2 million and $0.1 milliob for the three months endedMarch 31, 2009 and respectively. We expect to incur additionapl net lossesin 2009. On December 4, our board of directors approved the proposed Plan of subject toshareholder approval. The proposesd Plan of Dissolution providexs for the voluntary liquidation and dissolution of ourcompanh and, subject to the requirementss of Washington law, distribution of any available cash and otherr assets to our shareholders.
A special meeting of shareholders to vote on the Plan of Dissolutiob is scheduled to be held onMay 20, 2009. ...